# Auricular Point Stimulation Plus Dexamethasone Versus Standard Antiemetic Regimen for Nausea and Vomiting Caused by Gemcitabine Combined With Paclitaxel Protein

Source: https://onco.cc/trials/nct07716228/  
OnCo record `nct07716228` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of dexamethasone in pancreatic cancer, run by Second Affiliated Hospital, Zhejiang University, School of Medicine, now recruiting.

## Summary

Auricular Point Stimulation Plus Dexamethasone Versus Standard Antiemetic Regimen for Nausea and Vomiting Caused by Gemcitabine Combined With Paclitaxel Protein-bound is a phase 3, randomised interventional study registered as NCT07716228 by Second Affiliated Hospital, Zhejiang University, School of Medicine, with a registry enrolment figure of 74 participants, started 2025-12-12 and due to reach its primary completion in 2026-12-06. Interventions recorded: Auricular point stimulation plus dexamethasone; Standard pharmacologic antiemetic regimen. Conditions listed: Nausea and Vomiting Caused by Chemotherapy. Primary outcome: Proportion of patients experiencing nausea as assessed by NIC-CTC AE4.0. Pancreatic eligibility wording from the registry: "* Patients must meet the following inclusion criteria for the study: \* Age ≥ 18 years and ≤ 85 years; \* Patients with pancreatic cancer after radical resection or with advanced pancreatic cancer, who require further chemotherapy with the gemcitabine plus paclitaxel albumin-bound regimen; \* ECOG p". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Also known as: ADGP II
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT07716228
- Phase: 3
- Setting: Auricular Point Stimulation Plus Dexamethasone Versus Standard Antiemetic Regimen for Nausea and Vomiting Caused by Gemcitabine Combined With Paclitaxel Protein-bound in Pancreatic Cancer Treatment
- Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
- Enrolled: 74

## Sources

- ClinicalTrials.gov NCT07716228: https://clinicaltrials.gov/study/NCT07716228

## Connected records

- cancers: [Metastatic pancreatic ductal adenocarcinoma](https://onco.cc/cancers/metastatic-pdac/)
- drugs: [Dexamethasone](https://onco.cc/drugs/dexamethasone/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct07716228.json